Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer
about
Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Obatoclax and LY3009120 Effici ...... Differentiated Thyroid Cancer
@en
Obatoclax and LY3009120 Effici ...... Differentiated Thyroid Cancer.
@nl
type
label
Obatoclax and LY3009120 Effici ...... Differentiated Thyroid Cancer
@en
Obatoclax and LY3009120 Effici ...... Differentiated Thyroid Cancer.
@nl
prefLabel
Obatoclax and LY3009120 Effici ...... Differentiated Thyroid Cancer
@en
Obatoclax and LY3009120 Effici ...... Differentiated Thyroid Cancer.
@nl
P2093
P2860
P356
P1433
P1476
Obatoclax and LY3009120 Effici ...... Differentiated Thyroid Cancer
@en
P2093
Hong-Jun Song
Wei-Jun Wei
Xin-Yun Zhang
Zhen-Kui Sun
Zhong-Ling Qiu
P2860
P304
P356
10.7150/THNO.17322
P577
2017-02-23T00:00:00Z